Caricamento...
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Immune checkpoint blockade (ICB) has a limited effect on colorectal cancer, underlining the requirement of co‐targeting the complementary mechanisms. Here, we identified prostaglandin E2 (PGE(2)) receptor 4 (EP4) as the master regulator of immunosuppressive myeloid cells (IMCs), which are the major...
Salvato in:
| Pubblicato in: | EMBO Mol Med |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7799360/ https://ncbi.nlm.nih.gov/pubmed/33283987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012798 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|